WIN-Partners CoTSE:3183 +0.31%63 FCF Margin % is 2.39% as of Mar. 2026, which is 4% below its 10-year median of 2.48. GuruFocus rates TSE:3183 with a GF Score™ of 63/100 and a GF Value™ of 円1,522.55 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 115 Medical Distribution companies, WIN-Partners Co ranks better than 69.57% on this metric.
The historical rank and industry rank for WIN-Partners Co's FCF Margin % or its related term are showing as below:
TSE:3183'
s FCF Margin % Range Over the Past 10 Years
Min: -0.74 Med: 2.48 Max: 5.64
Current: 2.99
During the past 13 years, the highest FCF Margin % of WIN-Partners Co was 5.64%. The lowest was -0.74%. And the median was 2.48%.
TSE:3183's FCF Margin % is ranked better than 69.57% of 115
companies
in the Medical Distribution industry
Industry Median: 0.98
vs TSE:3183: 2.99
WIN-Partners Co FCF Margin % Related Terms
WIN-Partners Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for WIN-Partners Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3183 vs MCK, CAH, COR: FCF Margin % Comparison
For the Medical Distribution subindustry, WIN-Partners Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WIN-Partners Co FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where WIN-Partners Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WIN-Partners Co (TSE:3183) has a FCF Margin % of 2.39% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on WIN-Partners Co and its competitors. This is near median its historical median of 2.48. According to the industry distribution chart, WIN-Partners Co ranks #35 out of 115 companies in the Medical Distribution industry, placing it in the top 30.4%.
Is WIN-Partners Co's FCF Margin % too high?
WIN-Partners Co's current FCF Margin % of 2.39% is near median its 10-year median of 2.48. The Medical Distribution industry median FCF Margin % is 0.98. WIN-Partners Co's value of 2.39% is 143.9% above this industry median. Based on the distribution chart, WIN-Partners Co ranks #35 out of 115 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, WIN-Partners Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WIN-Partners Co's FCF Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, WIN-Partners Co ranks #35 out of 115 companies for FCF Margin %. This puts WIN-Partners Co in the upper half of its industry. The industry median FCF Margin % is 0.98. WIN-Partners Co's value of 2.39% is 143.9% above this benchmark. While the company's 10-year median is 2.48 vs. the industry median of 0.98, WIN-Partners Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 0.98, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WIN-Partners Co's current FCF Margin % of 2.39% is 143.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on WIN-Partners Co and its competitors. For the Medical Distribution industry, the median FCF Margin % is 0.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WIN-Partners Co's current FCF Margin % is 2.39%, which is near median its own 10-year median of 2.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WIN-Partners Co stock overvalued right now?
Based on GuruFocus' analysis, WIN-Partners Co (TSE:3183) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,522.55, compared to a current price of 円1,285.00 — trading 15.6% below its estimated fair value. The current FCF Margin % is 2.39%, which is near median its 10-year median of 2.48 and 143.9% above the Medical Distribution industry median of 0.98. WIN-Partners Co's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For WIN-Partners Co (TSE:3183), the current FCF Margin % is 2.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WIN-Partners Co (TSE:3183) Overvalued in 2026?
Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued.
The current stock price of 円1,285.00 is trading 15.6% below its estimated GF Value™ of 円1,522.55.
GuruFocus considers WIN-Partners Co to be Modestly Undervalued.
Key valuation signals for TSE:3183:
FCF Margin %: 2.39% (near median its 10-year median of 2.48)
GF Value™: 円1,522.55 vs. price of 円1,285.00 (15.6% below fair value)
Industry Position: 143.9% above the Medical Distribution median (#35 of 115)
No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
63GF Score
Get the complete analysis for TSE:3183
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3183 has been successfully added to your 
